Similar articles

• Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.

  Rajatanavin R, Mahatumarat P, Poochanugool L, Kumpolpunth S, Himathongkam T. Rajatanavin R, et al. J Med Assoc Thai. 1981 Jan;64(1):11-8. J Med Assoc Thai. 1981. PMID: 6163837 No abstract available.
• [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].

  Aliakparova ASh. Aliakparova ASh. Sov Med. 1973 Dec;36(12):45-8. Sov Med. 1973. PMID: 4130665 Russian. No abstract available.
• Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.

  Silverstein GE, Burke G. Silverstein GE, et al. Arch Intern Med. 1970 Oct;126(4):615-20. Arch Intern Med. 1970. PMID: 4097002 No abstract available.
• Antithyroid drugs.

  Cooper DS. Cooper DS. N Engl J Med. 2005 Mar 3;352(9):905-17. doi: 10.1056/NEJMra042972. N Engl J Med. 2005. PMID: 15745981 Review. No abstract available.
• Thyroid function after treatment of hyperthyroidism.

  [No authors listed] [No authors listed] Lancet. 1975 Sep 27;2(7935):590-1. Lancet. 1975. PMID: 51412 Review. No abstract available.